Huaren Pharmaceutical(SZ:300110) Xin Lang Cai Jing·2025-09-29 08:58Core Viewpoint - The company and its wholly-owned subsidiaries have actively participated in the bidding for the "3+N" alliance volume-based procurement project in the Beijing-Tianjin-Hebei region, achieving success in securing contracts for several products [1] Group 1: Company Participation - The company, along with its wholly-owned subsidiary Guangxi Yuyuan Pharmaceutical Co., Ltd. and Huaren Pharmaceutical (Rizhao) Co., Ltd., has engaged in the bidding process for the volume-based procurement [1] - The project number for the procurement is LH-YD2025-1, indicating a structured approach to the bidding process [1] Group 2: Procurement Results - The Tianjin Pharmaceutical Procurement Center has recently announced the results of the procurement, confirming that the company's products have been selected [1] - The selected products include mixed sugar electrolyte injection, betahistine hydrochloride sodium chloride injection, and hydroxyethyl starch 130/0.4 sodium chloride injection [1]